i-STAT G3+ cartridge; List Number: 03P78-26; Recall
i-STAT G3+ cartridge; List Number: 03P78-26;
FDA recall Class II
Ongoing
FDA lists this Class II recall for i-STAT G3+ cartridge; List Number: 03P78-26;. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2001-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Apr 1, 2026
- FDA report date
- May 6, 2026
- Quantity in commerce
- 40275 units (US only)
- Distribution
- See key details
- FDA cause
- Process change control
What is being recalled?
i-STAT G3+ cartridge; List Number: 03P78-26;
Affected model & UDI checker
Search the exact identifiers published for Z-2001-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | i-STAT G3+ cartridge; List Number: 03P78-26; | Check source notice | 00054749005673 |
FDA code information
List Number: 03P78-26; UDI-DI: 00054749005673; Lot number: N25221;
Why was this product recalled?
Approximately 7.6% of cartridges from specific i-STAT EG7+ (list number 03P76-25), i-STAT EG6+ (list number 03P77-25) and i-STAT G3+ (list number 03P78-26) cartridge lots in the U.S. marketplace may report higher than expected PCO2 and lower than expected pH results due to a manufacturing issue. A falsely high pCO2 together with a falsely low pH makes the blood gas appear as if the patient is in severe respiratory acidosis. If the clinician believes the values are real, it may trigger unnecessary or even harmful interventions such as unnecessary ventilator changes, unnecessary medications, potential harm from overcorrection, or delays in identifying true problems.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did Abbott Point of Care, Inc. take?
On April 1, 2026, URGENT MEDICAL DEVICE CORRECTION letters were sent to customers. This Urgent Medical Device Corrective is to customers in the U.S. with the following recommended actions: " Discontinue use of the affected i-STAT EG7+, EG6+, and G3+ cartridge lots for reporting PCO and pH results. " Use an alternate cartridge type, alternate lot, or testing method. " Complete and return the Business Reply Card included with this notification to confirm receipt and understanding. If you have forwarded any of the specified i-STAT EG7+, EG6+ or G3+ cartridges to another facility, we request that you please provide a copy of this letter to them.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2001-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology